Nationally-recognized sleep expert suggests that RLS is a meaningful BIOMARKER for serious disease
Posted: Thu Mar 14, 2024 6:07 pm
Dr. Sanford Auerbach is a board certified neurologist and a board certified sleep specialist.
For a period of time, Dr. Auerbach devoted part of his efforts to neurorehabilitation and managed the brain injury unit at Braintree Hospital, in addition to developing a clinical program for Alzheimer’s disease at Boston Medical Center. Dr. Auerbach directed all of his efforts to activities at Boston Medical Center and the School of Medicine. He also developed an interest in sleep medicine and became the director of the Sleep Disorders Center at Boston Medical Center. In recent years, his efforts have been split between Sleep Medicine and Behavioral Neurology with an emphasis on dementia.
From Science Daily:
"A nationally-recognized sleep expert has published an editorial describing Restless Legs Syndrome (RLS) as a possible biomarker for underlying disease.
The editorial appears in the March 5, 2014 issue of Neurology the medical journal of the American Academy of Neurology and was authored by Boston Medical Center neurologist Sanford H. Auerbach, MD.
The editorial was in response to an analysis of 12,556 men who were followed over time by the Health Professionals Follow-Up Study, published in the same issue of Neurology, which showed multiple disease associations with RLS.
'Patients with RLS had a higher mortality rate than similar men, and showed an especially strong tendency toward cardiovascular disease and hypertension' said Auerbach, associate professor of neurology and psychiatry at Boston University School of Medicine.
In earlier analyses of the same data, men with RLS were more likely to be diagnosed with lung disease, endocrine disease, diseases of nutrition and metabolism and immune system problems.
Auerbach suggests that restless leg syndrome is a meaningful biomarker for serious disease, and that RLS screening may become more common as a tool for primary care providers to identify patients at risk."
https://www.sciencedaily.com/releases/2 ... 191435.htm
For a period of time, Dr. Auerbach devoted part of his efforts to neurorehabilitation and managed the brain injury unit at Braintree Hospital, in addition to developing a clinical program for Alzheimer’s disease at Boston Medical Center. Dr. Auerbach directed all of his efforts to activities at Boston Medical Center and the School of Medicine. He also developed an interest in sleep medicine and became the director of the Sleep Disorders Center at Boston Medical Center. In recent years, his efforts have been split between Sleep Medicine and Behavioral Neurology with an emphasis on dementia.
From Science Daily:
"A nationally-recognized sleep expert has published an editorial describing Restless Legs Syndrome (RLS) as a possible biomarker for underlying disease.
The editorial appears in the March 5, 2014 issue of Neurology the medical journal of the American Academy of Neurology and was authored by Boston Medical Center neurologist Sanford H. Auerbach, MD.
The editorial was in response to an analysis of 12,556 men who were followed over time by the Health Professionals Follow-Up Study, published in the same issue of Neurology, which showed multiple disease associations with RLS.
'Patients with RLS had a higher mortality rate than similar men, and showed an especially strong tendency toward cardiovascular disease and hypertension' said Auerbach, associate professor of neurology and psychiatry at Boston University School of Medicine.
In earlier analyses of the same data, men with RLS were more likely to be diagnosed with lung disease, endocrine disease, diseases of nutrition and metabolism and immune system problems.
Auerbach suggests that restless leg syndrome is a meaningful biomarker for serious disease, and that RLS screening may become more common as a tool for primary care providers to identify patients at risk."
https://www.sciencedaily.com/releases/2 ... 191435.htm